Aflac Inc (AFL) stock
AFLNYSEAccident & Health InsuranceFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/308% below fair value
$125.27−2.42 (-1.90%)
Close on Nov 18, 2026Market cap $62.80BP/E 13.4Yield 1.85%
Aflac operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Aflac's operating income for the twelve months ending Sep 30, 2023 was $4.32B, down 1.9% year over year. For fiscal 2022 it was $4.16B, down 15.7% from the year before. Over ten years it grew -1.1% a year on average. The highest annual figure on record is $4.93B in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $4.16B | -15.7% |
| FY2021 | Dec 31, 2021 | $4.93B | +11.7% |
| FY2020 | Dec 31, 2020 | $4.42B | -1.0% |
| FY2019 | Dec 31, 2019 | $4.46B | +2.5% |
| FY2018 | Dec 31, 2018 | $4.35B | +6.5% |
| FY2017 | Dec 31, 2017 | $4.09B | -0.7% |
| FY2016 | Dec 31, 2016 | $4.12B | +2.9% |
| FY2015 | Dec 31, 2015 | $4.00B | -5.9% |
| FY2014 | Dec 31, 2014 | $4.25B | -3.3% |
| FY2013 | Dec 31, 2013 | $4.40B | -5.6% |
| FY2012 | Dec 31, 2012 | $4.66B | +3.5% |
| FY2011 | Dec 31, 2011 | $4.50B | +13.0% |
| FY2010 | Dec 31, 2010 | $3.98B | +16.0% |
| FY2009 | Dec 31, 2009 | $3.44B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | $1.30B | +17.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.14B | -0.2% |
| Q1 FY2023 | Mar 31, 2023 | $1.13B | -2.4% |
| Q4 FY2022 | Dec 31, 2022 | $750.00M | -24.5% |
| Q3 FY2022 | Sep 30, 2022 | $1.11B | -14.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.14B | -14.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.16B | -11.1% |
| Q4 FY2021 | Dec 31, 2021 | $994.00M | +3.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.29B | +24.7% |
| Q2 FY2021 | Jun 30, 2021 | $1.34B | +8.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.31B | +10.4% |
| Q4 FY2020 | Dec 31, 2020 | $961.00M | -6.1% |
| Q3 FY2020 | Sep 30, 2020 | $1.04B | -10.3% |
| Q2 FY2020 | Jun 30, 2020 | $1.24B | +8.0% |
| Q1 FY2020 | Mar 31, 2020 | $1.18B | +3.9% |
| Q4 FY2019 | Dec 31, 2019 | $1.02B | -2.1% |
| Q3 FY2019 | Sep 30, 2019 | $1.16B | +9.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.14B | +0.4% |
| Q1 FY2019 | Mar 31, 2019 | $1.14B | +2.7% |
| Q4 FY2018 | Dec 31, 2018 | $1.05B | +7.4% |
| Q3 FY2018 | Sep 30, 2018 | $1.06B | +4.6% |
| Q2 FY2018 | Jun 30, 2018 | $1.14B | +6.1% |
| Q1 FY2018 | Mar 31, 2018 | $1.11B | +8.0% |
| Q4 FY2017 | Dec 31, 2017 | $973.00M | +7.6% |
| Q3 FY2017 | Sep 30, 2017 | $1.01B | -7.1% |
| Q2 FY2017 | Jun 30, 2017 | $1.07B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.03B | – |
| Q4 FY2016 | Dec 31, 2016 | $904.00M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.09B | – |
See a number that looks wrong?